Industry Spotlight

Industry Spotlight on Aerie

Industry Spotlight on Aerie

‘Targeting the diseased tissue to restore normal function is a fundamental tenet of medicine, yet no available glaucoma therapies do this. We founded Aerie with the specific goal of bringing a safe and effective trabecular outflow drug to physicians and their patients.’1                                        -Dr. David Epstein (1943-2014) Former Duke University Chairman of the Department of Ophthalmology […]